Advisor Group Holdings, Inc. Uni Qure N.V. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Uni Qure N.V. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 115 shares of QURE stock, worth $1,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115

Previous 2,725 95.78%

Holding current value

$1,995

Previous $12,000 100.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.78 - $10.12 $9,865 - $26,413	-2,610 Reduced 95.78%	115 $0
Q2 2024 Aug 13, 2024	BUY	$4.39 - $5.43 $987 - $1,221	225 Added 9.0%	2,725 $12,000
Q1 2024 May 10, 2024	SELL	$4.82 - $6.93 $13,794 - $19,833	-2,862 Reduced 53.38%	2,500 $13,000
Q4 2023 Feb 12, 2024	SELL	$5.63 - $8.27 $54,571 - $80,161	-9,693 Reduced 64.38%	5,362 $36,000
Q3 2023 Nov 13, 2023	BUY	$6.71 - $11.83 $59,866 - $105,547	8,922 Added 145.48%	15,055 $101,000
Q2 2023 Aug 10, 2023	SELL	$11.12 - $22.2 $4,225 - $8,436	-380 Reduced 5.83%	6,133 $70,000
Q1 2023 May 12, 2023	BUY	$18.7 - $23.07 $3,609 - $4,452	193 Added 3.05%	6,513 $131,000
Q4 2022 Feb 10, 2023	SELL	$18.12 - $27.32 $32,235 - $48,602	-1,779 Reduced 21.97%	6,320 $143,000
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $16,317 - $24,543	-961 Reduced 10.61%	8,099 $153,000
Q2 2022 Aug 10, 2022	BUY	$13.15 - $20.45 $3,708 - $5,766	282 Added 3.21%	9,060 $170,000
Q1 2022 May 04, 2022	SELL	$14.54 - $21.5 $34,677 - $51,277	-2,385 Reduced 21.37%	8,778 $159,000
Q3 2021 Nov 05, 2021	SELL	$26.01 - $38.22 $4,863 - $7,147	-187 Reduced 1.65%	11,163 $358,000
Q2 2021 Aug 02, 2021	SELL	$29.97 - $37.17 $100,069 - $124,110	-3,339 Reduced 22.73%	11,350 $350,000
Q1 2021 May 13, 2021	BUY	$29.24 - $42.03 $92,398 - $132,814	3,160 Added 27.41%	14,689 $495,000
Q4 2020 Feb 10, 2021	BUY	$35.35 - $50.67 $16,190 - $23,206	458 Added 4.14%	11,529 $416,000
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $136,184 - $180,393	3,785 Added 51.95%	11,071 $407,000
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $3,785 - $5,690	84 Added 1.17%	7,286 $329,000
Q1 2020 May 18, 2020	BUY	$40.01 - $73.97 $288,152 - $532,731	7,202 New	7,202 $342,000

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $811M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Uni Qure N.V. Transaction History